Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,236,270,798
+$73,637,363 QoQ
Shares Held
3,413,981
+3.3% QoQ
Ownership
0.631%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#25
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 8%
None 7%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $19,386,650,383 across 15 Drug Manufacturers - General names. AMGN ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,003,417 | $4,801,818,850 | |
| 2 | JNJ |
Johnson & Johnson
|
15,385,556 | $3,907,469,656 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,486,486 | $2,247,013,450 | |
| 4 | ABBV |
AbbVie Inc.
|
7,236,861 | $1,821,083,699 | |
| 5 | NVS |
Novartis AG
|
8,117,586 | $1,272,188,077 | |
| 6 | AMGN |
Amgen Inc
This page
|
3,413,981 | $1,236,270,798 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,691,951 | $1,134,650,214 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,899,794 | $998,059,971 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,236,270,798 | 3,413,981 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,162,633,435 | 3,304,344 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,057,531,734 | 3,230,979 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $896,998,095 | 3,178,590 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $844,310,376 | 3,023,926 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $941,050,792 | 3,020,545 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $781,327,042 | 2,997,725 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $905,663,033 | 2,810,785 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $844,124,604 | 2,701,631 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $722,004,481 | 2,539,408 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $713,362,749 | 2,476,782 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $648,551,741 | 2,413,126 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $531,172,191 | 2,392,452 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $566,833,398 | 2,344,709 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $625,584,052 | 2,381,907 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $558,587,630 | 2,478,206 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $604,514,613 | 2,484,647 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $595,362,049 | 2,462,005 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $582,909,643 | 2,591,055 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $565,375,106 | 2,658,712 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $649,414,106 | 2,664,263 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $658,759,806 | 2,647,642 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $610,680,395 | 2,656,056 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $669,776,664 | 2,635,256 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $605,660,648 | 2,567,882 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $512,041,040 | 2,525,729 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||